The global Cell Culture Market size is valued at USD 31.22 billion in 2024 & is projected to reach USD 78.4 billion by 2032, growing at a CAGR of 12.2 % during the forecast years from 2024 to 2032.
Cell Culture Market Overview
Cell culture, also known as tissue culture, is a procedure of culturing cells under controlled situations, which is generally performed outside their natural environment. This is a crucial method in molecular and cellular biology that is carried out to investigate the typical physiology and biochemistry of cells, mutagenesis, and carcinogenesis, along with the impact of medications and toxic compounds on the cells. The cells of interest are preserved in vigilant monitoring conditions after being detached from living tissue through mechanical or enzymatic methods before cultivation. The major factors contributing to the market growth include a rising emphasis on monoclonal antibodies, coupled with the increasing responsiveness regarding the aids of cell-based vaccines. In addition, the increasing demand for monoclonal antibodies and the growing availability of research-associated funding are supporting the demand for cell culture across the globe.
COVID-19 Impact Analysis
The arrival of the coronavirus around the world has shown a huge impact on the global economy. The global Cell Culture Market has lucratively emerged during this pandemic owing to the cell culture methods acting a crucial role in the research of new disease-related treatments and diagnostics for the disease. As per the World Health Organization (WHO), on January 2020, the outbreak of COVID-19 was announced as a public health emergency, which affected approximately 210 countries worldwide. Accordingly, with the rising need to discover therapeutics to cure this deadly virus the demand for cell lines and different cell culture techniques was on the rise. Also, various scientists and researchers were engaged to comprehend the disease at a molecular level, in which primary cell culture gained huge popularity to understand the lung mechanism and target the pathogen processes during this period.
Market Segmentation:
The global Cell Culture Market is segmented on the basis of Product (Consumables, Equipment), Consumables (Sera, Media, and Reagents, Vessels, Accessories), Equipment (Telemedicine, Patient Monitoring), Application (Biopharmaceutical Production {Monoclonal antibodies, Vaccines production, Other therapeutic proteins}, Diagnostics, Drug Screening & Development, Tissue Engineering & Regenerative Medicine {Cell and gene therapy, Other tissue engineering & regenerative medicine applications}, Other Applications), by End User (Pharmaceutical & Biotechnology Companies, Hospitals & Diagnostic Laboratories, Research & Academic Institutes, Other End Users)
The consumable segment is expected to be the largest segment of the Cell Culture Market
Based on the product segment, the consumables sub-segment dominated the market and accounted for the largest revenue share in 2024. Factors such as the flourishing demand for consumables in various research and development applications and the rising availability of customized alternatives propel the segment’s growth. Additionally, the surging demand for consumables from the various academic research institutes, contract research institutions, biopharmaceutical companies, and contract manufacturers and increasing incidences of many diseases are likely to support the segment demand. Moreover, the equipment segment is projected to register the fastest CAGR over the forecast period due to the growing focus on personalized medicine and the increasing requirement to maintain high-quality standards.
Market Dynamics:
Drivers:
Rising responsiveness regarding the benefits of cell-based vaccines
The threat of new virus infections has grown because of climate change, the rise in population, and more animal-human contact. The sudden outbreak of COVID-19 and Influenza is unproven that risks the lives of people along with the economy. The World Health Organization (WHO) reported 386.55 million confirmed cases that involve 5.71 million deaths caused by COVID-19 as of February 4, 2022. Likewise, according to the Centers for Disease Control and Prevention, it was estimated that there were 23,000 people died from flu during the period 2015-16. Also, the figure grew and reached 28,000 cases of deaths during 2018-19. Thereby, the rising burden of pandemics, as well as increasing incidences of infectious diseases is fueling the demand for vaccines. Accordingly, cell culture has emerged as a significant component of vaccine development in the pharmaceutical industry. Cell culture technology is gaining high traction in manufacturing vaccines such as hepatitis, polio, chickenpox, rubella, smallpox, and rotavirus. Thus, rising awareness of the advantages of cell culture-based vaccinations and the regulatory approval of numerous cell culture-based vaccines are considered crucial factors that are anticipated to boost the growth of the cell culture market during the forecasting year.
Regional Analysis:
North America is expected to account for the largest regional market size in 2024.
The global cell culture market has been categorized into North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. North America is estimated to dominate the global market with the largest market shares. The rising support of the regulatory bodies, increasing approvals for cell culture-based vaccines, and growing availability of research and development funding are majorly contributing to the regional market growth. In addition, increasing investment in technological advancements, along with the exponential growth of the regional pharmaceutical & biotechnology industries is creating lucrative opportunities over the forecasting years.
Key Market Players & Competitive Landscape
Some of the key market players operating in the global market are:
- Agilent Technologies, Inc. (US)
- Caisson Laboratories Inc. (US)
- Danaher Corporation (US)
- HI Media laboratories (India)
- Thermo Fisher Scientific Inc. (US)
- Sartorius AG (Germany)
- Becton, Dickinson, and Company (US)
- Lonza Group AG (Switzerland)
- FUJIFILM Irvine Scientific, Inc. (Japan)
- STEMCELL Technologies Inc. (Canada)
- Solida Biotech GmbH (Germany)
- Merck KGaA (Germany)
- Eppendorf AG (Germany)
- Corning Incorporated (US)
- Miltenyi Biotec (Germany)
- Meissner Filtration Products Inc. (US)
The Beyond Market Insights research has segmented the Global Cell Culture Market report on the basis of Product, Consumables, Equipment, Application, End User, and region
Cell Culture Market By Product Outlook:
- Consumables
- Equipment
Cell Culture Market By Consumables Outlook
- Sera, Media, and Reagents
- Vessels
- Accessories
Cell Culture Market By Equipment Outlook
- Telemedicine
- Patient Monitoring
Cell Culture Market By Application Outlook
- Biopharmaceutical Production
- Monoclonal antibodies
- Vaccines production
- Other therapeutic proteins
- Diagnostics
- Drug Screening & Development
- Tissue Engineering & Regenerative Medicine
- Cell and gene therapy
- Other tissue engineering & regenerative medicine applications
- Other Applications
Cell Culture Market By End User Outlook
- Pharmaceutical & Biotechnology Companies
- Hospitals & Diagnostic Laboratories
- Research & Academic Institutes
- Other End Users
Cell Culture Market By Regional Outlook
- North America
- Europe
- France
- Germany
- UK
- Italy
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- South Korea
- Australia
- Rest of the APAC
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- UAE
- Saudi Arabia
- Israel
- South Africa
- Rest of the Middle East & Africa
